Jia-ji Z. Jiang

Fuzhou, 350109, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Temperature-induced structural evolution in liquid Bi86.8Au13.2 alloy.

Temperature-induced structural evolution in liquid Bi86.8Au13.2 alloy.

Journal: The Journal of chemical physics

Published: May 11, 2025

Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure.

Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure.

Journal: Expert review of gastroenterology & hepatology

Published: January 02, 2024

Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B.

Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B.

Journal: Journal of hepatology

Published: September 30, 2023

Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection.

Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection.

Journal: Alimentary pharmacology & therapeutics

Published: August 09, 2023

Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers.

Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers.

Journal: Journal of medical virology

Published: February 12, 2023

Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase.

Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase.

Journal: Journal of clinical and translational hepatology

Published: July 14, 2022

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.

Journal: World journal of gastroenterology

Published: April 12, 2022

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.

Journal: Journal of clinical and translational hepatology

Published: February 25, 2022

Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection.

Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection.

Journal: World journal of gastroenterology

Published: November 26, 2020

Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection.

Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection.

Journal: Clinics and research in hepatology and gastroenterology

Published: December 12, 2018

Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.

Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.

Journal: World journal of gastroenterology

Published: June 27, 2017

Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.

Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.

Journal: World journal of gastroenterology

Published: July 10, 2016

Showing 1-12 of 32

Last Updated: 09/26/2026